Home » Newsletters » BioWorld Asia

BioWorld Asia

April 8, 1998

View Archived Issues

OGS In US$50M Pfizer Deal; Raises £31M In LSE Float

Natural Enzyme Activity May Improve Gene Therapy

Swedish, Danish Health Sectors Attract US$537M In Two Years

Lion Bioscience Reports Dynamic First-Year Operations

Biota's Flu Drug Submitted For Approval In Australia

Oxagen Raises £8M In Financing For Gene Identification Programs

Cambridge Antibody, Progenitor Team Up For Drug Discovery

Gemini, Affymetrix To Study Genetic Links To Osteoporosis

Biomira To Sell Diagnostics Subsidiary To Centocor

Agen Valued Higher Than Proposed Takeover Bid

Pharmos Gets 2 FDA Approvals; Eyes First Drug Revenues

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.